Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BCPC logo BCPC
Upturn stock ratingUpturn stock rating
BCPC logo

Balchem Corporation (BCPC)

Upturn stock ratingUpturn stock rating
$161.99
Last Close (24-hour delay)
Profit since last BUY-1.9%
upturn advisory
Consider higher Upturn Star rating
BUY since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: BCPC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $200.33

1 Year Target Price $200.33

Analysts Price Target For last 52 week
$200.33 Target price
52w Low $145.7
Current$161.99
52w High $184.99

Analysis of Past Performance

Type Stock
Historic Profit -9.75%
Avg. Invested days 38
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.26B USD
Price to earnings Ratio 37.15
1Y Target Price 200.33
Price to earnings Ratio 37.15
1Y Target Price 200.33
Volume (30-day avg) 2
Beta 0.89
52 Weeks Range 145.70 - 184.99
Updated Date 08/29/2025
52 Weeks Range 145.70 - 184.99
Updated Date 08/29/2025
Dividends yield (FY) 0.53%
Basic EPS (TTM) 4.36

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 14.48%
Operating Margin (TTM) 20.3%

Management Effectiveness

Return on Assets (TTM) 7.66%
Return on Equity (TTM) 11.99%

Valuation

Trailing PE 37.15
Forward PE 36.63
Enterprise Value 5399666714
Price to Sales(TTM) 5.33
Enterprise Value 5399666714
Price to Sales(TTM) 5.33
Enterprise Value to Revenue 5.48
Enterprise Value to EBITDA 22.3
Shares Outstanding 32455200
Shares Floating 32283505
Shares Outstanding 32455200
Shares Floating 32283505
Percent Insiders 0.37
Percent Institutions 90.93

ai summary icon Upturn AI SWOT

Balchem Corporation

stock logo

Company Overview

overview logo History and Background

Balchem Corporation was founded in 1967. Initially focused on encapsulation technology, Balchem has grown through organic expansion and strategic acquisitions, evolving into a global leader in specialty ingredients.

business area logo Core Business Areas

  • Human Nutrition & Health: Supplies ingredients for food and beverage, and dietary supplement markets, including encapsulated nutrients and minerals.
  • Animal Nutrition & Health: Provides solutions to improve animal health and productivity, including chelated minerals, rumen-protected nutrients, and feed supplements.
  • Specialty Products: Offers products for industrial applications, including choline chloride and other performance chemicals used in various industries.

leadership logo Leadership and Structure

Ted Harris is the Chairman, President, and CEO. The company operates with a functional organizational structure with distinct business segments, each led by a vice president, reporting to the CEO.

Top Products and Market Share

overview logo Key Offerings

  • VitaCholine: Choline ingredient used in dietary supplements and infant formula. Balchem holds a significant market share in the global choline market. Competitors include Jubilant Ingrevia, BASF, and Alkyl Amines Chemicals.
  • Reashure: Rumen-protected choline for dairy cows, designed to improve milk production and overall health. Balchem is a leading provider in this market. Competitors include DuPont, ADM, and Cargill.
  • AminoShure-XM: Precision release rumen protected lysine that is used to ensure the animal receives the nutrients needed to thrive. Competitors include DuPont, ADM, and Cargill.

Market Dynamics

industry overview logo Industry Overview

The specialty ingredients market is driven by increasing demand for healthier food and beverage options, growing animal protein consumption, and advancements in encapsulation technology.

Positioning

Balchem is positioned as a leader in encapsulation and chelation technologies, enabling delivery of nutrients and functional ingredients. Its focus on science-backed solutions gives it a competitive advantage.

Total Addressable Market (TAM)

The global specialty ingredients market is estimated at hundreds of billions USD. Balchem focuses on specific niches within these broader markets, targeting growth opportunities with high-value products and solutions. Balchem holds a percentage of this TAM.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Leading technology in encapsulation and chelation
  • Diversified product portfolio
  • Global presence
  • Strong financial performance

Weaknesses

  • Reliance on specific suppliers for raw materials
  • Exposure to commodity price fluctuations
  • Limited brand recognition outside core markets
  • Dependence on key patents

Opportunities

  • Expansion into new geographic markets
  • Development of innovative products
  • Acquisitions of complementary businesses
  • Growing demand for specialty ingredients
  • Increase in pet ownership

Threats

  • Increased competition
  • Changes in regulations
  • Economic downturns
  • Raw material price volatility
  • Intellectual property infringement

Competitors and Market Share

competitor logo Key Competitors

  • IFF (IFF)
  • DSM (DSM.AS)
  • ADM (ADM)

Competitive Landscape

Balchemu2019s competitive advantage lies in its strong technology platform, diversified product portfolio, and focus on high-value markets. Competitors have broader portfolios but may lack Balchemu2019s specialization.

Major Acquisitions

Performance Chemicals

  • Year: 2016
  • Acquisition Price (USD millions): 93.9
  • Strategic Rationale: Expanded Balchem's Specialty Products segment by adding choline chloride and other performance chemicals.

Bergstrom Nutrition

  • Year: 2020
  • Acquisition Price (USD millions): 133.5
  • Strategic Rationale: Expanded Balchem's Human Nutrition & Health segment by adding OptiMSM.

Growth Trajectory and Initiatives

Historical Growth: Balchem has achieved consistent revenue and earnings growth through organic expansion and strategic acquisitions.

Future Projections: Analysts project continued revenue and earnings growth, driven by demand for specialty ingredients and expansion into new markets. The projected earnings growth rate is at low double digits %.

Recent Initiatives: Recent initiatives include acquisitions, expansion of manufacturing facilities, and investments in research and development.

Summary

Balchem Corporation shows a strong business model with a proven track record of growth through strategic acquisitions and innovative product development. They hold a robust position in their niche markets, though reliance on raw material suppliers and potential commodity price volatility are risks. Future growth is expected to continue with expansion into new markets and continued investment in R&D. Overall, Balchem is fundamentally solid but needs to monitor competition and manage supply chain risks.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Balchem Corporation's Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Analyst Reports
  • Company Press Releases
  • Market Research Reports

Disclaimers:

This analysis is based on publicly available information and should not be considered financial advice. Market conditions can change rapidly, and past performance is not indicative of future results.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Balchem Corporation

Exchange NASDAQ
Headquaters Montvale, NJ, United States
IPO Launch date 1986-06-03
CEO, President & Chairman Mr. Theodore Lee Harris
Sector Basic Materials
Industry Specialty Chemicals
Full time employees 1364
Full time employees 1364

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.